AP
DPLO

AHL Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

AHL Partners’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,951
Closed -$413K – 1417
2017
Q3 		$413K Sell
19,951
-39,339
-66% -$665K 0.01% 1096
2017
Q2 		$877K Buy
59,290
+15,270
+35% +$255K 0.02% 821
2017
Q1 		$702K Buy
+44,020
New +$635K 0.02% 888
2016
Q4 		– Sell
-120,481
Closed -$3.37M – 1250
2016
Q3 		$3.37M Buy
+120,481
New +$4.04M 0.13% 249

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AHL Partners's DPLO Position: Q4 2017 in Review

AHL Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 19,951 shares — an estimated $413K sold.

AHL Partners first reported a position in DPLO in Q3 2016 and held it in 4 quarters. The position peaked at $3.37M in Q3 2016. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • AHL Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 19,951 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $413K.
  • AHL Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 4 quarters.
  • AHL Partners's DIPLOMAT PHARMACY, INC. position peaked at $3.37M in Q3 2016.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.